Loading clinical trials...
Loading clinical trials...
Active treatment, dose-blinded extension study evaluating the safety and long term efficacy of sildenafil citrate in children with PAH.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT07218029 · Pulmonary Arterial Hypertension
NCT07120789 · Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), and more
NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension
NCT04778046 · Interstitial Lung Disease, COPD, and more
NCT06481852 · Pulmonary Arterial Hypertension
Pfizer Investigational Site
Palo Alto, California
Pfizer Investigational Site
Palo Alto, California
Pfizer Investigational Site
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions